ASPET

December 28, 1908December 28, 1908

April 5-8, 2008April 5-8, 2008

San Diego, CaliforniaSan Diego, California

Centennial SymposiaCentennial SymposiaFormat

Introductory talk highlighting history of field3-4 Speakers addressing the most recent advances of the fieldConcluding talk posting where the field is likely to go in the next few years & its implications for improving human healthThe very best people in the field

Centennial SymposiaCentennial SymposiaThe Obesity Epidemic – Pharmacological Challenges P450s: Structure, Function, In Silico Predictions The G-Whizards of GPCR/G-Protein Signaling Chance favors the prepared mind: A Nobel perspective New Experimental Approaches to Treatment of Schizophrenia: Moving Beyond Monoamine Antagonists Development of inhibitors of the soluble epoxide hydrolase as a novel treatment for hypertension, vascular inflammation and end organ damage Pharmacotherapy of Cocaine AbuseNew Concepts in an Old System: RAS Blockade as Therapy for General Cardiovascular DiseaseModels in Drug Discovery: Past, Present, FutureFocus on Pharmacogenomics

Special PublicationsSpecial PublicationsHistory of the Nobel Research that Shaped Modern PharmacologyWomen in PharmacologyCentennial PerspectivesSignificant Deciles - 100 Years of Pharmacology in a Social, Historical & Cultural Context History of the SocietyInterviews with ASPET’s Executive OfficersPoster-100 years of pharmacology (sponsored by Cephalon, Inc.)

Meeting Compendium – Meeting Compendium – free to all ASPET registered attendees at EB’08 (sponsored by Aldolor, Inc.)

Abel NumberAbel Number What is an Abel number?

Well, if you were John Jacob Abel, your Abel number would be 0. If you published with J. J. Abel, your Abel number would be 1. If you published with someone who published with J. J. Abel, your Abel number would be 2. And so on.

Do I have an Abel number & how do I find out what it is?

http://www.aspet.org/public/Centennial/Abel_number.htm

Or more simply

www.aspet.org and click on featured link to the Abel Number

Abel NumberAbel Number

SponsorshipSponsorship

New AwardsNew Awards

Formerly given by Cathecholamine Club

2007 Winner - Tong H. Joh, Ph.D.

Supported by Eli Lilly, Wyeth Research & Abbott Labs

Julius Axelrod Symposium in 2008 as part of Centennial Meeting

Julius Axelrod Award

ASPET-Astellas Awards $30,000 Awards (plus travel/registration for annual

meeting)

Supported by a grant from the Astellas Foundation

Intended to recognize pharmacological research accomplishments that seek to extend fundamental research closer to applications directed towards improving human health

2007 Winners- P. Jeffrey Conn (Vanderbilt), Kathryn Cunningham (University of Texas Health Science Center), Liewei Wang (Mayo Clinic)

JournalsJournals

Editor 2000-2006 Darrell Abernethy, NIA, NIH

Pharmacological Pharmacological ReviewsReviews

Editor 2006-2009 Ross Feldman, University of Western

Ontario Deputy Editor, Eric Brass, Harbor-UCLA

Medical Center

JournalsJournals

Centennial PerspectivesPerspectives on the Past 100 Years of

Pharmacological Research

Short reviews (2-12 pages) on important topics in pharmacology & therapeutics summarizing the development of knowledge on the topic over the last century plus speculation on future developments

One article per issue in each of the 5 journals published by the Society

Commence in 2007 and continue through 2008

Authors will be solicited by members of the BPT but volunteers will be enthusiastically considered.

If interested or have suggestions for topics, contact Rich Dodenhoff Journals Director, ([email protected]).

Molecular InterventionsMolecular Interventions

Consider advertising your graduate programs

October issue distributed at Annual Biomedical Research Conference for Minority Students, SACNAS meeting, & Society for Neuroscience meeting

Molecular InterventionsMolecular Interventions

Public AffairsPublic Affairs

FDA Alliance100-member non-partisan coalition of patient and consumer groups, PhRMA and professional societies focused on advocacy to the public, media and CongressPurpose - to unite interested organizations in support of increased resources for the FDA to support its mission as a science-based agency

Integrative & Organ Systems Science

Meeting of interested industry partners in Spring 2006Establishment of IOSS FundMerck Fellowships

Member ServicesMember Services

Suzie Thompson – Member Services/ Marketing Manager

“It was the best of times. It was the worst of times.”

A Tale of Two Cities by Charles Dickens

New membership database & membership management system – September 2007